Beyond the Prescription Pad: The Emerging Role of Acute Neuromodulation
For the patient texting your office at 3 PM with a migraine — Here is a solution to have on hand!
It’s a familiar scenario.
A patient messages the office mid-afternoon.
The migraine started a few hours ago.
They’ve already used their usual rescue medication this week.
They’re worried about taking more.
And they’re looking for relief now.
For many clinicians, these conversations highlight one of the biggest challenges in migraine care: acute treatment options are essential, but they aren’t always straightforward.
Some patients cannot tolerate certain medications.
Others are trying to avoid medication overuse.
And some paitents have reached the point where every refill discussion feels like a reminder that they’re relying on acute medications more than they’d like.
Increasingly, neuromodulation is becoming part of that conversation.
Not as a replacement for every acute migraine therapy—but as another tool patients may be able to reach for when they need it most.
Acute Migraine Care Is About More Than Stopping Pain
When patients experience a migraine attack, their goal is simple: make it stop. But from a clinical perspective, the goal is often broader.
We want effective symptom relief.
We want to preserve function.
And we want to avoid creating additional problems through excessive medication use.
That balancing act can become difficult, particularly for patients who experience frequent migraine attacks.
The more often a patient requires acute treatment, the more important it becomes to think strategically about how those attacks are managed.
That’s where acute neuromodulation has generated growing interest.
What Acute sTMS Can Do
Single-pulse transcranial magnetic stimulation (sTMS) is a non-invasive neuromodulation approach designed to influence neural activity associated with migraine.
Unlike medications, sTMS does not introduce a pharmacologic agent into the body. Instead, it delivers brief magnetic pulses intended to affect migraine-related brain activity.
Research has demonstrated that sTMS may provide benefit for some patients when used during migraine attacks, particularly when treatment is initiated early in the course of symptoms.
For clinicians, one of the most appealing aspects of acute neuromodulation is that it offers a fundamentally different treatment mechanism than traditional rescue medications.
For patients, it is even simpler:
It’s something they can use immediately.
No pharmacy visit.
No refill request.
No concern about adding another medication to an already complicated regimen.
That does not mean it works for everyone, nor should it be viewed as a cure. But it does expand the range of options available when a migraine begins.
The Medication Overuse Headache Challenge
One of the most frustrating cycles in migraine care involves medication overuse headache (MOH).
Patients experience frequent migraine attacks.
They use acute medications more often.
Headaches become more frequent.
The need for acute medication increases further.
Over time, patients can find themselves caught in a difficult pattern that is challenging to break.
Medication overuse headache remains a significant clinical concern and one of the reasons healthcare providers carefully monitor the frequency of acute medication use.
This is where non-pharmacologic options may offer an important advantage.
Because neuromodulation devices do not rely on medications, they provide an alternative acute treatment pathway that can be incorporated into broader strategies aimed at reducing medication burden.
While devices are not a standalone solution for MOH, they may help some patients broaden their acute management approach and reduce reliance on rescue medications over time.
For patients struggling with frequent attacks, that possibility can be meaningful.
Empowering Self-Management
One of the most overlooked aspects of migraine care is the importance of patient confidence.
Patients who feel helpless during an attack often experience significant anxiety around when the next migraine will occur.
Many begin planning their lives around medication availability.
Will they have enough medication left?
Can they refill the prescription in time?
What happens if symptoms start while traveling?
Acute neuromodulation changes that conversation in a subtle but important way. It gives patients another action they can take when symptoms begin.
That sense of control matters.
Effective migraine management is not only about reducing headache days. It’s also about helping patients feel capable of managing their condition.
For some patients, having a non-drug treatment option available at home becomes part of that process.
Expanding the Acute Treatment Toolbox
Migraine attacks do not always happen at convenient times.
They happen during work meetings.
On family vacations.
During school pickups.
And, sometimes, in the middle of an ordinary Tuesday afternoon.
As clinicians, our responsibility is to equip patients with options that fit the realities of their lives. Acute neuromodulation is not the answer for every patient.
But it represents an increasingly important addition to the migraine treatment toolbox—particularly for those seeking alternatives to additional medication use or looking to reduce their reliance on acute pharmacologic therapies.
Sometimes the most valuable treatment isn’t the next prescription.
It’s giving patients another way to respond when migraine strikes.
References
- Lipton RB, Dodick DW, Silberstein SD, et al. Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomized, double-blind, parallel-group, sham-controlled trial. The Lancet Neurology. 2010;9(4):373-380.
- Puledda F, Goadsby PJ. An update on non-invasive neuromodulation for migraine and cluster headache. Cephalalgia. 2017;37(7):685-691.
- Moisset X, Pereira B, Ciampi de Andrade D, et al. Neuromodulation techniques for acute and preventive migraine treatment: a systematic review and meta-analysis of randomized controlled trials. The Journal of Headache and Pain. 2020;21(1):142.
- Marmura MJ, et al. Patient-Centered Treatment of Chronic Migraine With Medication Overuse. Neurology. 2022.
- American Headache Society. Consensus Statement: Update on Integrating New Migraine Treatments Into Clinical Practice. Headache. 2021.
- International Classification of Headache Disorders, 3rd edition (ICHD-3). Medication-Overuse Headache Diagnostic Criteria.
